Jerome D. Cohen

发表

Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group.

J. Cutler, J. Neaton, W. G. Walker, 1992 .

The Effects of Nonpharmacologic Interventions on Blood Pressure of Persons With High Normal Levels: Results of the Trials of Hypertension Prevention, Phase I

N. Cook, J. Buring, P. Whelton, 1992 .

Use of health information technology (HIT) to improve statin adherence and low-density lipoprotein cholesterol goal attainment in high-risk patients: proceedings from a workshop.

Alan S. Brown, Matthew K. Ito, D. Karalis, 2013, Journal of clinical lipidology.

The sixth report of the Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure

Henry R. Black, Norman M. Kaplan, H. Black, 1998 .

Mental Stress–Induced Ischemia and All-Cause Mortality in Patients With Coronary Artery Disease: Results From the Psychophysiological Investigations of Myocardial Ischemia Study

David Sheffield, Peter G. Kaufmann, Kenneth E. Freedland, 2002, Circulation.

Hypertension in the elderly: Age- and disease-related complications and therapeutic implications

J. Fleg, E. Lakatta, Jerome D. Cohen, 1993, Cardiovascular Drugs and Therapy.

The Changing Landscape of Hypertension and the Evolving Role of Vasodilatory Beta-Blockers

G. Bakris, Jerome D. Cohen, E. Gonzalez, 2015 .

Case study: pearls in hypertension pharmacotherapy.

Jerome D. Cohen, 2007, Journal of managed care pharmacy : JMCP.

Cardioprotection: The Role of β‐Blocker Therapy

B. Egan, Jerome D. Cohen, J. Basile, 2005, Journal of clinical hypertension.

Lipoprotein particles, insulin, adiponectin, C-reactive protein and risk of coronary heart disease among men with metabolic syndrome.

L. Kuller, R. Prineas, J. Neaton, 2007, Atherosclerosis.

Pathophysiologic and Therapeutic Importance of Tissue ACE: A Consensus Report

E. Lonn, K. Swedberg, H. Schunkert, 2002, Cardiovascular Drugs and Therapy.

Renal Disease in Hypertensive Blacks: MRFIT-Reply

R. Neuwirth, J. Cutler, J. Neaton, 1993 .

The National Lipid Association surveys of consumers, physicians, and pharmacists regarding an over-the-counter statin in the United States: is this a good idea?

J. Mckenney, Jerome D. Cohen, W. Brown, 2004, The American journal of cardiology.

Rationale for Aggressive Lipid Lowering in High-Risk Patients

Jerome D. Cohen, 2011, The Journal of the American Osteopathic Association.

Managing the Patient with Hypertriglyceridemia: A Practical Approach for Nurse Practitioners

Jerome D. Cohen, Frances M. Rankin (Sahebzamani], 2008, Journal of the American Academy of Nurse Practitioners.

Azithromycin for the secondary prevention of coronary events.

R. Kronmal, W. Rogers, J. Crouse, 2005, The New England journal of medicine.

Asymptomatic Cardiac Ischemia Pilot study (ACIP)

A. Baker, P. Stone, L. McDaniel, 1992, American Journal of Cardiology.

Metabolic syndrome is associated with muscle symptoms among statin users.

Jerome D. Cohen, T. A. Jacobson, K. Maki, 2016, Journal of clinical lipidology.

Behavioral Patterns and Their Implications Weight Control Both cross-sectional and prospective observational studies have

R. Lefebvre, B. Falkner, Jerome D. Cohen, 2005 .

ABCs of secondary prevention of CHD: easier said than done

Jerome D. Cohen, 2001, The Lancet.

Cryptosporidium in acquired immunodeficiency syndrome

Jerome D. Cohen, W. Snape, M. Tong, 1984, Digestive Diseases and Sciences.

Long-term prognostic significance of isolated minor electrocardiographic T-wave abnormalities in middle-aged men free of clinical cardiovascular disease (The Multiple Risk Factor Intervention Trial [MRFIT]).

R. Prineas, P. Rautaharju, Jerome D. Cohen, 2002, The American journal of cardiology.

Understanding physician and consumer attitudes concerning cholesterol management: results from the National Lipid Association surveys.

J. Mckenney, R. Pasternak, Jerome D. Cohen, 2004, The American journal of cardiology.

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.

Carl J Pepine, Giuseppe Mancia, H Robert Kolb, 2003, JAMA.

Torsades de pointes, a potential complication of diuretic-induced hypokalemia and hypomagnesemia in patients with congestive heart failure: Conference presentation of a generic patient

R. Blumenthal, Jerome D. Cohen, W. Weglicki, 2002 .

The influence of the metabolic syndrome on 24-year mortality among middle-aged men in the multiple risk factor intervention trial (MRFIT)

L. Eberly, R. Prineas, Jerome D. Cohen, 2003 .

Recognition and Treatment of Homozygous Familial Hypercholesterolemia by Primary Care Physicians: a Survey from the National Lipid Association

D. Karalis, K. Hovingh, A. Goldberg, 2020, Journal of General Internal Medicine.

Dietary sodium intake and mortality MRFIT follow-up study results

J. Cutler, J. Neaton, J. Stamler, 1999 .

The effect of fish oil on blood pressure and high‐density lipoprotein‐cholesterol levels in phase I of the Trials of Hypertension Prevention

J. Cutler, L. Kuller, N. Borhani, 1994, Journal of hypertension.

Smoking Is a Risk Factor for Coronary Spasm in Young Women

M. Kern, Jerome D. Cohen, D. Caralis, 1992, Circulation.

Long-Term Weight Loss and Changes in Blood Pressure: Results of the Trials of Hypertension Prevention, Phase II

N. Milas, I-Min Lee, Victor Stevens, 2001, Annals of Internal Medicine.

Serving the Underserved: Are We Overlooking HoFH Patients?

D. Karalis, A. Goldberg, Jerome D. Cohen, 2019, Journal of Clinical Lipidology.

Provider recommendations for patient-reported muscle symptoms on statin therapy: Insights from the Understanding Statin Use in America and Gaps in Patient Education survey.

Jerome D. Cohen, K. Maki, E. Brinton, 2017, Journal of clinical lipidology.

Part 10: Analysis

B. Davis, L. Kuller, J. Wittes, 1991 .

Metabolic syndrome: risk factor distribution and 18-year mortality in the multiple risk factor intervention trial.

L. Kuller, L. Eberly, R. Prineas, 2006, Diabetes care.

Effect of health information technology interventions on lipid management in clinical practice: a systematic review of randomized controlled trials.

D. Karalis, Jerome D. Cohen, K. Aspry, 2013, Journal of clinical lipidology.

Overview of physiology, vascular biology, and mechanisms of hypertension.

Jerome D. Cohen, Jerome D Cohen, 2007, Journal of managed care pharmacy : JMCP.

Troponin I in patients without chest pain.

Jerome D. Cohen, L. Hsu, Hyung D. Chung, 2004, Clinical chemistry.

Understanding Statin Use in America and Gaps in Patient Education (USAGE): an internet-based survey of 10,138 current and former statin users.

Matthew K Ito, Eliot A Brinton, Matthew K. Ito, 2012, Journal of clinical lipidology.

Gender differences in side effects and attitudes regarding statin use in the Understanding Statin Use in America and Gaps in Patient Education (USAGE) study.

D. Karalis, Jerome D. Cohen, R. Wild, 2016, Journal of clinical lipidology.

Predictors of development of diabetes mellitus in patients with coronary artery disease taking antihypertensive medications (findings from the INternational VErapamil SR-Trandolapril STudy [INVEST]).

G. Bakris, F. Messerli, C. Pepine, 2006, The American journal of cardiology.

Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability.

Jerome D. Cohen, M. Ernst, B. Carter, 2004, Hypertension.

Multiple Risk Factor Intervention Trial Revisited: A New Perspective Based on Nonfatal and Fatal Composite Endpoints, Coronary and Cardiovascular, During the Trial

J. Cutler, L. Kuller, L. Eberly, 2012, Journal of the American Heart Association.

Impact of incident diabetes and incident nonfatal cardiovascular disease on 18-year mortality: the multiple risk factor intervention trial experience.

L. Eberly, R. Prineas, Jerome D. Cohen, 2003, Diabetes care.

Characteristics of Cases and Controls in Study of Premenopausal Women With Coronary Vasospasm Cases

M. Kern, Jerome D. Cohen, D. Caralis, 2005 .

Risk factors for stroke and type of stroke in persons with isolated systolic hypertension

Alan C. Wilson, B. Davis, L. Brass, 1998 .

Predictors of statin adherence, switching, and discontinuation in the USAGE survey: understanding the use of statins in America and gaps in patient education.

Matthew K Ito, Eliot A Brinton, Matthew K. Ito, 2013, Journal of clinical lipidology.

30-year trends in serum lipids among United States adults: results from the National Health and Nutrition Examination Surveys II, III, and 1999-2006.

A. Wallace, Jerome D. Cohen, T. Wasser, 2010, The American journal of cardiology.

Lung cancer mortality after 16 years in MRFIT participants in intervention and usual-care groups

J. Cutler, L. Kuller, J. Ockene, 1997 .

Hypertension epidemiology and economic burden: refining risk assessment to lower costs.

Jerome D. Cohen, 2009, Managed care.

Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.

P. Kowey, G. Mancia, S. Bangalore, 2008, American heart journal.

Managing Hypertension: State of the Science

Jerome D. Cohen, 2006, Journal of clinical hypertension.

Pulse pressure and cardiovascular disease-related mortality: follow-up study of the Multiple Risk Factor Intervention Trial (MRFIT).

M. Pfeffer, M. Domanski, G. Mitchell, 2002, JAMA.

Short report : the effect of fish oil on blood pressure and high-density lipoprotein-cholesterol levels in phase I of the trials of hypertension prevention

J. Cutler, L. Kuller, N. Borhani, 1994 .

Muscle symptoms in statin users, associations with cytochrome P450, and membrane transporter inhibitor use: a subanalysis of the USAGE study.

Matthew K. Ito, Jerome D. Cohen, K. Maki, 2014, Journal of clinical lipidology.

Long‐Term Effectiveness of Enalapril plus Extended‐Release Diltiazem in Essential Hypertension

Jerome D. Cohen, W. Applegate, P. Wolfson, 1997, Pharmacotherapy.

Abstract 1189: Changes in the Prevalence of Abnormal Lipid Fractions among US Adults: Results from the National Health and Nutrition Examination Survey II, III, and 1999-2006

A. Wallace, Jerome D. Cohen, M. Cziraky, 2008 .

Characteristics of contemporary patients with hypertension and coronary artery disease

P. Kowey, G. Mancia, F. Messerli, 2004, Clinical cardiology.

The STatin Adverse Treatment Experience Survey: Experience of patients reporting side effects of statin therapy.

Jerome D. Cohen, Mona L. Martin, K. Maki, 2019, Journal of clinical lipidology.

Barriers to PCSK9 inhibitor prescriptions for patients with high cardiovascular risk: Results of a healthcare provider survey conducted by the National Lipid Association.

D. Karalis, Jerome D. Cohen, K. Maki, 2017, Journal of clinical lipidology.

Teaching Medical Students How to Talk with Patients about Cardiovascular Risk Factor Modification

Jerome D. Cohen, J. Henderson, W. Merkel, 1987, International quarterly of community health education.

901-6 Psychophysiological Investigations of Myocardial Ischemia (PIMI): Initial Results on Mechanisms of Cardiac Ischemia

R. Bonsall, P. Kaufmann, P. Stone, 1995 .

Superior physicians and the treatment of hypertension.

Jerome D. Cohen, 2002, Archives of internal medicine.

A Model Clinical Program for Patients With Diabetes and Vision Impairment

Jerome D. Cohen, P. Duckro, S. Albert, 1989, The Diabetes educator.

Heart rate adjustment of exercise-induced ST-segment depression identifies men who benefit from a risk factor reduction program.

P. Kligfield, P. Okin, R. Prineas, 1997, Circulation.

Sex differences in chest pain in patients with documented coronary artery disease and exercise-induced ischemia: Results from the PIMI study.

R. Bonsall, R. Carney, K. Freedland, 2001, American heart journal.

The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data.

E. Lonn, K. Swedberg, H. Schunkert, 2001, The American journal of cardiology.

P. Kowey, G. Mancia, S. Bangalore, 2008, American heart journal.

A case of data alteration in the Multiple Risk Factor Intervention Trial (MRFIT). The MRFIT Research Group.

J. Neaton, Jerome D. Cohen, S. Broste, 1991, Controlled clinical trials.